Prognosis of ALS: Comparing data from the Limousin referral centre, France, and a Uruguayan population

References

• Beghi, E, Millul, A, Logroscino, G, Vitelli, E, Micheli, A; SLALOM GROUP. Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:163–7.
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008; 79: 33–7
   PubMed Web of Science ®Google Scholar
• O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008; 79: 30–2
   PubMed Web of Science ®Google Scholar
• Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population based registry. Neuroepidemiology. 2005; 25: 114–9
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Cran GW, Swingler RJ. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neuron disease J Neurol Neurosurg Psychiatry. 2004; 75: 1753–5
   Google Scholar
• del Aguila MA, Longstreth WT, Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003; 60: 813–9
   PubMed Web of Science ®Google Scholar
• Chiò A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population based study. Neurology. 2002; 59: 99–103
   PubMed Web of Science ®Google Scholar
• Tysnes OB, Vollset SE, Larsen JP, Aarli JA. Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology. 1994; 13: 226–35
   PubMed Web of Science ®Google Scholar
• Christensen PB, Hojer-Pedersen E, Jensen NB. Survival of patients with amyotrophic lateral sclerosis in two Danish counties. Neurology. 1990; 40: 600–4
   PubMed Web of Science ®Google Scholar
• Gil J, Preux PM, Alioum A, Ketzoian C, Desport JC, Druet-Cabanac M, et al. Disease progression and survival in ALS: first multi-state model approach. Amyotroph Lateral Scler. 2007; 8: 224–9
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol. 2006; 253: 1428–36
   PubMed Web of Science ®Google Scholar
• Thijs V, Peeters E, Theys P, Matthijs G, Robberecht W. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population. Acta Neurol Belg. 2000; 100: 84–90
   PubMed Web of Science ®Google Scholar
• Louwerse ES, Visser CE, Bossuyt PM, Weverling GJ. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium. J Neurol Sci. 1997; 152(Suppl 1)S10–7
   PubMed Web of Science ®Google Scholar
• Preux PM, Couratier P, Boutros-Toni F, Salle JY, Tabaraud F, Bernet-Bernady P, et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology. 1996; 15: 153–60
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995; 118: 707–19
   PubMed Web of Science ®Google Scholar
• Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve. 1993; 16: 27–32
   PubMed Web of Science ®Google Scholar
• Werneck LC, Bezerra R, Silveira Neto O, Scola RH. A clinical epidemiological study of 251 cases of amyotrophic lateral sclerosis in the south of Brazil. Arq Neuropsiquiatr. 2007; 65: 189–95
   PubMed Web of Science ®Google Scholar
• Castro-Costa CM, Oriá RB, Vale OC, Arruda JA, Horta WG, D'Almeida JA, et al. Motor neuron diseases in the university hospital of Fortaleza (north-eastern Brazil): a clinico-demographic analysis of 87 cases. Arq Neuropsiquiatr. 2000; 58: 986–9
   PubMed Web of Science ®Google Scholar
• Dietrich-Neto F, Callegaro D, Dias-Tosta E, Silva HA, Ferraz ME, Lima JM, et al. Amyotrophic lateral sclerosis in Brazil: 1998 national survey. Arq Neuropsiquiatr. 2000; 58: 607–15
   PubMed Web of Science ®Google Scholar
• Dubrovsky AL, Sica RE. Current treatment pathways in ALS: a South American perspective. Neurology. 1999; 53: S11–6
   PubMed Web of Science ®Google Scholar
• Galdames D, Aguilera L, Riveros JM, Arce C. Epidemiology of amyotrophic lateral sclerosis in Santiago. A retrospective study. Rev Med Chil. 1980; 108: 435–9
   PubMed Web of Science ®Google Scholar
• Vázquez MC, Ketzoian C, Legnani C, Rega I, Sánchez N, Perna A, et al. Incidence and prevalence of amyotrophic lateral sclerosis in UY: a population based study. Neuroepidemiology. 2008; 30: 105–11
   PubMed Web of Science ®Google Scholar
• Chiò A. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol. 1999; 246(Suppl 3)1–5
   Google Scholar
• Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci. 1995; 132: 207–15
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study,1996–2000. J Neurol Neurosurg Psychiatry. 2003; 74: 1258–61
   PubMed Web of Science ®Google Scholar
• Chiò, A, Bottacchi, E, Buffa, C, Mutani, R, Mora, G; PARALS. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77:948–50.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística (INE): Anuario estadístico 2005. Montevideo, INE, 2005. Available athttp://www.ine.gub.uy/.
   Google Scholar
• Institut Nationale de la Statistique et des Etudes Economiques (INSEE). Available athttp://www.insee.fr/.
   Google Scholar
• Observatoire Régionale de la Santé du LIM: Chiffres clés. Available athttp://www.ors-LIM.org/.
   Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases /Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci. 1994; 124(Suppl)96–107
   PubMed Web of Science ®Google Scholar
• . Aid to the investigation of peripheral nerve injuriesMedical Research Council. War memorandum2nd edn.,revised. London: His Majesty's Stationery Office. 1943:11–46.
   Google Scholar
• , ALS CNTF Treatment Study Phase I–II GroupBrooks, BR, Sanjak, M, Ringel, S, England, J, Brinkmann, J, , et al. The ALS functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol. 1996;53:141–7.
   PubMedGoogle Scholar
• Preux PM, Druet-Cabanac M, Couratier P, Debrock C, Marcharia W, Dumas M. Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France. J Clin Epidemiol. 2000; 53: 1025–9
   PubMed Web of Science ®Google Scholar
• Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted, Minnesota, 1925 to 1998. Neurology. 2002; 59: 280–2
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Lepore V, et al. ALS multidisciplinary clinic and survival. Results from a population based study in southern Italy. J Neurol. 2007; 254: 1107–12
   PubMed Web of Science ®Google Scholar